美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

中國生物製藥ADR

15.89

0.0000

成交量：- -

成交額：- -

市值：144.64億

市盈率：30.32

高：15.89

開：15.89

低：15.89

收：15.89

52周最高：20.16

52周最低：8.76

股本：9.10億

流通股本：4.58億

量比：0.70

換手率：- -

股息：0.24

股息率：1.51%

每股收益(TTM):0.5241

每股收益(LYR):0.5242

淨資產收益率：15.40%

總資產收益率：5.07%

市淨率：2.99

市盈率(LYR):30.31

資料載入中...

總覽公司新聞資訊公告

正大天晴與賽諾菲達成超15億獨家授權；諾和諾德MASH新適應症擬納入優先審評；全球首款宮頸癌前病變無創治療藥物獲批上市

中國生物製藥：集團自主研發的1類創新藥羅伐昔替尼上市獲得藥監局上市批准

同類首創引領骨髓纖維化治療新時代，正大天晴羅伐昔替尼獲批上市

CPHI制药在线

【券商聚焦】中泰國際指港股受地緣政治影響，科技與資源股表現分化

政府夥29間大型企業為香港青年提供海內外暑期實習機會

阿斯达克财经

港股指數早盤衝高回落恒指半日升0.54 受壓居前新東方(09901)跌4.71%

醫藥生物行業周報：併購與授權合作持續活躍，關注創新藥領域資源整合加速

中國生物製藥慢乙肝1類新藥Ⅱ期臨床達主要終點，為低病毒血症提供新方案

正大制药订阅号

25年恒指累漲近28%：中國宏橋暴漲203.72%居成份股榜首，近10只個股翻倍

中國生物製藥獲副總裁兼執行董事謝炘增持100萬股每股作價約6.41港元

18款1類新藥首次獲批臨床！中國生物製藥2025年多領域創新破局，全球化研發體系再深化

正大制药订阅号

熱搜第一！「進口抗癌假藥」1500元一盒，有效成分卻為0

中国基金报

【券商聚焦】中州國際指恒指短期承壓，關注醫藥及能源板塊

脱髮新藥III期成功；創新藥出海新模式誕生

利好密集來襲！創新藥概念大爆發

东方财富研究中心

2025年西藥行業市場發展現狀趨勢分析

中國生物製藥又一款 1 類新藥首次啓動臨床

丁香园 Insight 数据库

中國生物製藥(1177HK)：PDE3/4抑制劑II期臨床數據亮眼市場潛力巨大

大健康行業周報 |13億，「中國美敦力」完成交割；東星醫療：擬以支付現金方式購買武漢醫佳寶90%的股權

華源證券-醫藥行業周報信立泰：全面佈局CKM管線，創新出海加速推進-250928

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SBHMY/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SBHMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBHMY\",,,,,undefined,":{"symbol":"SBHMY","market":"US","secType":"STK","nameCN":"中國生物製藥ADR","latestPrice":15.89,"timestamp":1774036800000,"preClose":15.89,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":457950931,"shares":910273459,"eps":0.524054,"marketStatus":"休市中","change":0,"latestTime":"03-20 16:00:00 EDT 延時","open":15.89,"high":15.89,"low":15.89,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.524054,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":20,"exchange":"PINK LIMITED","adjPreClose":15.89,"volumeRatio":0.7024825319453931},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBHMY\",,,,,undefined,":{"symbol":"SBHMY","floatShares":457950931,"roa":"5.07%","roe":"15.40%","lyrEps":0.524215,"volumeRatio":0.7024825319453931,"shares":910273459,"dividePrice":0.24027,"high":15.89,"amplitude":0,"preClose":15.89,"low":15.89,"week52Low":8.755,"pbRate":"2.99","psRate":"3.27","week52High":20.16,"institutionHeld":0,"latestPrice":15.89,"eps":0.524054,"divideRate":0.015121,"volume":0,"delay":15,"ttmEps":0.524054,"open":15.89,"prevYearClose":18.22,"prevWeekClose":15.89,"prevMonthClose":15.89,"prevQuarterClose":18.22,"fiveDayClose":15.89,"twentyDayClose":15.89,"sixtyDayClose":18.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBHMY\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"SBHMY","amount":0.127855,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-29","defaultRemindTime":1756474200000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-08","payableDate":"2025-08-29","currency":"USD","dateTimestamp":1756440000000,"payDate":"2025-10-08"},{"date":"2025-06-17","symbol":"SBHMY","amount":0.102066,"announcedDate":"2025-05-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-17","defaultRemindTime":1750167000000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-25","payableDate":"2025-06-17","currency":"USD","dateTimestamp":1750132800000,"payDate":"2025-07-25"},{"date":"2024-09-12","symbol":"SBHMY","amount":0.065379,"announcedDate":"2024-08-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-12","defaultRemindTime":1726147800000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-18","payableDate":"2024-09-12","currency":"USD","dateTimestamp":1726113600000,"payDate":"2024-10-18"},{"date":"2024-09-11","symbol":"SBHMY","amount":0.076916,"announcedDate":"2024-08-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-11","defaultRemindTime":1726061400000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-18","payableDate":"2024-09-11","currency":"USD","dateTimestamp":1726027200000,"payDate":"2024-10-18"},{"date":"2024-06-12","symbol":"SBHMY","amount":0.076829,"announcedDate":"2024-05-29","type":"dividend","market":"US","newRecordDate":"2024-06-12","defaultRemindTime":1718199000000,"name":"中国生物制药ADR","recordDate":"2024-07-22","payableDate":"2024-06-12","currency":"USD","dateTimestamp":1718164800000,"payDate":"2024-07-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBHMY\",market:\"US\",,,undefined,":[{"executeDate":"2018-09-10","recordDate":"2018-09-11","paymentDate":"2018-10-15","value":0.040958,"currency":"USD"},{"executeDate":"2018-12-04","recordDate":"2018-12-05","paymentDate":"2019-01-07","value":0.041124,"currency":"USD"},{"executeDate":"2019-06-13","recordDate":"2019-06-14","paymentDate":"2019-07-19","value":0.040963,"currency":"USD"},{"executeDate":"2019-09-11","recordDate":"2019-09-12","paymentDate":"2019-10-15","value":0.040986,"currency":"USD"},{"executeDate":"2019-12-09","recordDate":"2019-12-10","paymentDate":"2020-01-13","value":0.041103,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBHMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5833,"hold":0.0417,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":24,"updateTime":1758686400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBHMY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617554669","title":"正大天晴與賽諾菲達成超15億獨家授權；諾和諾德MASH新適應症擬納入優先審評；全球首款宮頸癌前病變無創治療藥物獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2617554669","media":"药财社","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617554669?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 18:59","pubTimestamp":1772708377,"startTime":"0","endTime":"0","summary":"2诺和诺德MASH新适应症拟纳入优先审评3月3日，国家药监局药品审评中心官网显示，诺和诺德旗下司美格鲁肽注射液新适应症在国内申请上市，并拟纳入优先审评。此前，该药物已于2025年8月获美国FDA批准。3全球首款宫颈癌前病变无创治疗药物获批上市3月3日晚间，亚虹医药发布公告，其核心产品APL-1702正式获得国家药监局批准上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305191315a44f9681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305191315a44f9681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNY","BK4599","LU1093756325.SGD","SBHMY","IE00BKVL7J92.USD","01177","NVOH","BK4588","BK4585","IE00BZ1G4Q59.USD","BK4532","LU0154236417.USD","LU1093756168.USD","NVO","BK4007","NVOX"],"gpt_icon":1},{"id":"2616332509","title":"中國生物製藥：集團自主研發的1類創新藥羅伐昔替尼上市獲得藥監局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332509","media":"财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332509?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 17:26","pubTimestamp":1772443607,"startTime":"0","endTime":"0","summary":"近日，中国生物制药发布公告称，集团自主研发的国家1类创新药罗伐昔替尼片已获得中国国家药品监督管理局的上市批准，适用于中危-2或高危的原发性骨髓纤维化、真性红细胞增多症后骨髓纤维化或原发性血小板增多症后骨髓纤维化成年患者的一线治疗。在一项多中心、随机、双盲、双模拟、阳性药物平行对照的II期临床研究中，罗伐昔替尼对比羟基尿在治疗中危-2、高危骨髓纤维化患者中展示出优异的疗效和良好的安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302173018a731073c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302173018a731073c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMF","SBHMY","BK4007"],"gpt_icon":0},{"id":"2616533268","title":"同類首創引領骨髓纖維化治療新時代，正大天晴羅伐昔替尼獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533268","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616533268?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 16:27","pubTimestamp":1772440050,"startTime":"0","endTime":"0","summary":"此次罗伐昔替尼获批是基于一项随机、双盲、阳性对照2期关键研究。其次，抗纤维化与疾病修饰将成为药物研发的核心目标，下一代治疗药物将更加注重降低基因突变负荷、逆转骨髓纤维化进程、延长患者总生存期，而罗伐昔替尼的ROCK抑制机制恰好契合这一研发方向，具备天然的研发优势。总结全球MF靶向治疗已从JAK单靶点迈入多靶点协同时代，正大天晴罗伐昔替尼片以全球首创JAK/ROCK双重抑制剂的身份，为中高危MF患者带来革命性治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030216463297a7a138&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030216463297a7a138&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SBHMY","PMF"],"gpt_icon":0},{"id":"2613636877","title":"【券商聚焦】中泰國際指港股受地緣政治影響，科技與資源股表現分化","url":"https://stock-news.laohu8.com/highlight/detail?id=2613636877","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613636877?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 11:03","pubTimestamp":1771902192,"startTime":"0","endTime":"0","summary":"金吾财讯|中泰国际发布研报指，前一交易日港股在缺乏南向资金下仍强势上涨，恒生指数升2.5%收报27,081点，恒生科技指数涨3.3%报5,385点。地缘政治紧张推动国际金价突破5,100美元，带动资源股普涨，紫金矿业及灵宝黄金分别升5.3%和6.2%。AI板块显著回调，智谱因产品问题股价暴跌22.8%。美股受地缘风险拖累全线下跌，道琼斯指数跌1.6%，市场避险情绪升温。宏观层面，国内春节旅游数据亮眼，飞猪平台国内游订单量创新高，高星级酒店人均预订量近3晚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224112242a4c12729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224112242a4c12729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MPNGY","LU3063872942.SGD","LU0130103400.USD","LU0203345920.USD","LU0359202008.SGD","SG9999015986.USD","01177","SGXZ90724238.SGD","BK1505","LU2051468812.USD","SG9999000327.SGD","LU1044874839.SGD","SG9999001226.SGD","LU0328353924.USD","BK1544","BK1575","SGXZ81514606.USD","LU0455707207.USD","LU0052750758.USD","LU0067412154.USD","IE00B031HY20.USD","LU0345776255.USD","LU0683595622.HKD","LU0254981946.USD","IE00B031J352.USD","LU1642822792.SGD","LU0143863198.USD","LU0588545730.USD","LU2362541513.USD","LU2293587155.HKD","LU1115378108.SGD","LU0164872284.USD","LU0572939691.SGD","LU0650527681.SGD","LU1366334651.USD","BK1502","LU0196878994.USD","LU1481107354.HKD","LU2125910849.SGD","LU1814569148.SGD","LU0531970944.HKD","LU0588545904.SGD","SG9999018857.SGD","BK1515","LU0326948709.USD","LU0878004406.USD","LU0784639295.USD","LU0327786744.USD","LU1785774172.SGD","BK1249","LU1064131003.USD","BK1594","LU0128522744.USD","LU0084288322.USD","LU0605514214.HKD","LU1548497426.USD","LU2125910500.SGD","LU1282649810.SGD","LU0516422440.USD","BK1095","LU0898667661.SGD","BK1592","LU0499858602.USD","LU0577902371.SGD","LU0501845795.SGD","LU0823413660.USD","LU1733274473.HKD","LU0642271901.SGD","SG9999014914.USD","BK1584","LU1316542783.SGD","LU0607220059.USD","IE00B8L5B284.USD","LU0164880469.USD","LU0456827905.SGD","HK0000320264.USD","LU1328615791.USD","LU0648000940.SGD","LU2279701549.SGD","LU0509642566.USD","LU1883866441.USD","LU1725190679.HKD","LU0823426480.USD","LU0873338254.USD","BK1618","LU0828237940.HKD","LU0080751232.USD","LU1515016050.SGD","LU0588545490.SGD","LU0463099449.HKD","SG9999007991.SGD","LU0441854154.USD","LU1880398471.USD","LU0823040885.USD","LU1226287529.USD","LU1282649141.HKD","IE00B067MR52.USD","LU2045819591.USD","LU0320764243.SGD","02899","LU0229945570.USD","LU0871576103.HKD","LU1720050803.USD","LU1810669033.SGD","IE0001KFT4U8.USD","IE0003895053.USD","LU0251144936.SGD","LU0620787316.HKD","LU0235996351.USD","LU2226246903.HKD","SG9999015945.SGD","LU2097828805.USD","LU1224444064.USD","LU0370786039.SGD","LU0572944931.SGD","LU1282649067.USD","LU0082770016.SGD","HK0000352382.USD","LU1282651121.HKD","LU0287142896.SGD","LU1303224171.USD","LU0348827113.USD","LU1224709979.USD","LU0011963245.USD","LU0456846285.SGD","LU0611395673.USD","HMTD.SI","LU0540923850.HKD","LU1733274390.USD","SG9999006514.SGD","LU0737861699.HKD","LU0348723411.USD","LU0384037296.USD","LU0651946864.USD","LU1831875114.USD","LU1993786604.SGD","LU2247934214.USD","SG9999018865.SGD","LU1718418525.SGD","LU0140636845.USD","LU2237443622.USD","LU2097828474.EUR","LU2462611646.USD","LU0868486357.SGD","SG9999001846.SGD","02595","LU0577902298.EUR","LU0047713382.USD","LU1720051108.HKD","09988","LU0348784397.USD","LU0516422366.SGD","LU1880383366.USD","LU0054450605.USD","LU0823038988.USD","LU1226288097.SGD","LU1023057109.AUD","LU2265009873.SGD","BK1609","IE0003851619.USD","LU0594300419.USD","IE0008369823.USD","LU2237443978.SGD","IE00BQXX3F31.USD","LU0823039010.USD","LU0543330483.HKD","LU1868837722.USD","SG9999014906.USD","LU0132412106.USD","LU0314109678.HKD","LU0345780281.USD","LU0049853897.USD","LU0543330566.HKD","LU0269904917.USD","LU0828237510.HKD","LU1044875133.USD","LU0163747925.USD","LU2362540622.SGD","LU0315179316.USD","LU0127658192.USD","LU0043850808.USD","LU2106854487.HKD","LU1951186391.HKD","LU1196710351.USD","LU0106252389.USD","ALBmain","LU0359201612.USD","LU0985320562.USD","LU1046422090.SGD","HK0000914686.HKD","LU0082770016.USD","LU0456854461.SGD","HK0000165453.HKD","LU2023250504.SGD","LU2097829019.USD","LU0972618739.USD","IE00B29SXG58.USD","HK0000352291.HKD","LU0348783233.USD","LU0738912210.USD","IE00B0JY6N72.USD","LU0791591158.USD","LU0289960550.SGD","BK1117","LU1226287875.USD","LU0329678170.USD","LU1568876335.HKD","LU0417516571.SGD","LU0797268264.HKD","LU2097828631.EUR","LU0572940350.SGD","LU0675040207.SGD","LU0828238088.HKD","HK0000306685.HKD","SG9999002828.SGD","LU2177674079.SGD","LU0700851271.USD","LU1105468828.SGD","BK1517","LU0143863784.USD","LU0791590937.USD","LU0049112450.USD","LU0181495838.USD","LU1629966141.USD","SG9999001069.SGD","SG9999014880.SGD","LU0577902538.SGD","LU2476274308.USD","LU0651947912.USD","LU1051769294.HKD","LU0762540952.USD","HBBD.SI","IE00BMPRXR70.SGD","LU2317271919.USD","LU0117844026.USD","LU0106259558.USD","LU0640798160.USD","LU1044876610.USD","LU0819121731.USD","LU1366334578.USD","IE00BQXX3D17.EUR","LU0593848301.USD","LU0577902454.USD","LU1282651048.USD","LU0072913022.USD","LU0819123356.HKD","LU0594300179.USD","601899","LU1008478684.HKD","IE00BZ08YR35.GBP","LU2498475776.HKD","IE0032431581.USD","LU0786609619.USD","00700","LU0165289439.USD","LU0737861772.HKD","LU0107464264.USD","LU0128522157.USD","IE00B031HW06.USD","METmain","LU0417516738.SGD","LU0348814723.USD","LU0051755006.USD","LU0499858438.USD","LU0516422952.EUR","LU0259732245.USD","LU1769817096.USD","SG9999004220.SGD","BK1198","LU0762542818.HKD","LU0823426308.USD","LU1226288253.USD","SG9999001093.SGD","LU0345769128.USD","LU0096374516.USD","LU1242518857.USD","LU2449936058.SGD","LU0307460666.USD","LU0541502299.USD","LU2237443895.HKD","LU0823397103.USD","BK1591","LU0048580855.USD","LU0862451837.USD","LU0823413587.USD","LU2237443382.USD","LU0072462343.USD","LU1201861165.SGD","LU0228367735.SGD","LU1917777945.USD","LU1048484197.HKD","LU1226287792.SGD","LU0054237671.USD","LU2257852520.SGD","LU2362541273.HKD","LU0293314216.USD","LU2237443549.SGD","LU0048597586.USD","LU0633140560.USD","IE00B3M56506.USD","LU2133065610.SGD","BK1583","GB00BDT5M118.USD","IE00B5MMRT66.SGD","LU0918141887.USD","LU0029874905.USD","LU0414403682.SGD","LU2251237306.USD","LU0541501648.USD","LU0469268626.HKD","LU0608807433.USD","LU1981816686.USD","LU0169518387.USD","LU1769817179.HKD","LU1675838814.USD","LU0821914370.USD","SG9999001689.USD","LU1770034418.SGD","LU0762541174.USD","LU2399975544.HKD","LU0345775950.USD","LU1439102457.SGD","LU0831093199.SGD","LU1880398554.USD","LU1974910355.USD","LU0149721374.USD","LU0396098781.USD","LU0348735423.USD","LU0890818403.SGD","LU0345780521.USD","TCEHY","89988","LU1196710864.SGD","LU0633140727.USD","LU1719994722.HKD","LU1102505929.USD","LU1807302812.USD","LU2488822045.USD","BK1531","LU0210527791.USD","LU0417516902.SGD","BK1521","LU1328277881.USD","LU0516423091.SGD","LU0431992006.USD","LU0214875030.USD","LU0029875118.USD","LU0488056044.USD","HTCD.SI","LU2778985437.USD","BABA","IE0008368411.USD","HK0000320223.HKD","LU0708995153.HKD","BK1588","LU0192582467.USD","BK1142","IE00B8HQ1Z84.USD","IE00BZ08YS42.EUR","BK1610","LU0449515922.USD","LU1282648689.USD","LU0348816934.USD","LU1152091754.HKD","LU0588546209.SGD","LU0326950275.SGD","IE0003795394.USD","LU0210526637.USD","BK1604","LU0264606111.USD","LU0823041008.USD","LU0456842615.SGD","LU1323998911.USD","LU0261950983.USD","IE0031814852.USD","LU0531971595.HKD","03330","BK1501","LU1196710195.USD","LU1102505762.USD","LU1235295612.USD","LU1794554557.SGD","LU0173614495.USD","SG9999000459.SGD","SGXZ86797644.SGD","SG9999017495.SGD","LU0061477393.USD","LU0261947096.USD","LU2152927971.USD","LU1152091168.USD","LU1961090484.USD","LU0708995583.HKD","SG9999014674.SGD","LU2357305700.SGD","LU1242518931.SGD","IE00BZ08YT58.USD","LU0880133367.SGD","LU1804176565.USD","LU1048596156.SGD","LU1808992512.USD","LU0070217475.USD","LU0608807946.USD","BK1516","IE00B543WZ88.USD","LU1880383440.USD","LU0882747503.HKD","LU0878005551.USD","LU1226288170.HKD","LU1688375341.USD","LU1868837565.USD","HK0000306701.USD","IE00B0169L03.USD","LU0348788117.USD","SG9999013353.USD","LU1868838027.USD","LU0320764755.SGD","LU0048388663.USD","SG9999001903.USD","SG9999006597.SGD","SG9999002463.SGD","LU0561508036.HKD","LU0320764599.SGD","LU1504937902.USD","BK1615","LU0577902611.USD","IE00B97KM107.HKD","LU0315178854.USD","LU1439103000.SGD","BK1608","LU2148510915.USD","LU0117841782.USD","LU0672654166.SGD","LU0865486749.SGD","BK1586","03690","LU0329678337.USD","LU1956131251.USD","IE0008368304.USD","LU0210533765.USD","LU1051768304.USD","SG9999003461.SGD","IE00BF5LJ272.USD","LU0164939612.USD","LU0149534421.HKD","LU0862451753.SGD","SG9999002562.SGD","IE00B0169N27.USD","LU1960683339.HKD","LU2251237488.HKD","LU0211977185.USD","LU0345769631.USD","LU0348783662.USD","SGXZ62798434.SGD","LU0203347892.USD","LU2097828714.EUR","BK1589","LU0634319403.HKD","LU0630378692.HKD","LU0449509016.USD","ZIJMY","LU0918141705.HKD","IE00BPRC5H50.USD","SGXZ31699556.SGD","IE0009570106.USD","LU1211504680.USD","LU0886674414.USD","LU0164865239.USD","LU0244354667.USD","IE00BQXX3C00.GBP","LU2087589342.USD","LU0630378429.USD","LU2008162690.USD","SG9999014898.SGD","LU0831103253.SGD","LU2476274720.SGD","LU2237443465.HKD","LU0188438112.USD","LU2097828557.USD","LU1064130708.USD","LU1188198961.HKD","LU0348805143.USD","BK1233","SG9999000418.SGD","LU1568876251.USD","LU0197773160.USD","LU0266512127.USD","LU0823397285.USD","LU0106959298.USD","BK1191","LU0856984785.SGD","LU0516423174.USD","LU0231483743.USD","LU0266512473.USD","LU0211331839.USD","LU0979878070.USD","SG9999015978.USD","SG9999001051.SGD","LU2039709279.SGD","LU1813983027.USD","IE00BMPRXN33.USD","IE0032834883.USD","LU0359201885.HKD","IE0034224299.USD","LU0130518102.USD","LU0648948544.HKD","LU1251922891.USD","LU2242644610.SGD","LU0477156797.USD","HK0000914660.USD","BK1161","LU0197773673.USD","LU0502904849.HKD","LU0348825331.USD","LU1770036033.HKD","IE00BGV7N243.SGD","BK1526","SGXZ99366536.SGD","LU0039217434.USD","LU0589944569.HKD","TCHmain","LU0228659784.USD","LU1655091459.SGD","SGXZ51526630.SGD","LU0175139822.USD","LU1734074674.USD","IE0008368742.USD","SBHMY","LU1048588211.SGD","LU1720051017.SGD","SG9999015952.SGD"],"gpt_icon":1},{"id":"2610419995","title":"政府夥29間大型企業  為香港青年提供海內外暑期實習機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2610419995","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610419995?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 09:13","pubTimestamp":1770858780,"startTime":"0","endTime":"0","summary":"政府与29间大型企业合作推出民青局企业内地与海外暑期实习计划2026，为香港青年提供内地和海外暑期实习机会，企业包括腾讯、中华煤气、中银香港、恒隆地产及中国生物制药等。实习岗位遍布中国内地多个省市，包括多个粤港澳大湾区内地城市、北京、上海、成都、重庆及杭州等；海外国家则包括印尼、马来西亚、菲律宾、新加坡、泰国及澳洲等。沽空资料截至 2026-02-11 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220802134615382_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220802134615382_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1502838/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1502838/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1527","LU0320764243.SGD","LU0955648018.USD","LU2237443382.USD","LU0287142896.SGD","LU0289960550.SGD","SG9999015978.USD","82388","LU1725190679.HKD","LU0577902371.SGD","LU1951186391.HKD","LU1105468828.SGD","LU0047713382.USD","LU2106854487.HKD","LU1974910355.USD","LU0516423174.USD","LU1323998911.USD","LU0593848301.USD","LU2362541273.HKD","LU0886674414.USD","IE0003895053.USD","LU2476274308.USD","LU0828237510.HKD","LU1282651048.USD","SG9999007991.SGD","LU0132412106.USD","LU0633140727.USD","LU1046422090.SGD","LU0821914370.USD","HK0000914660.USD","LU0499858602.USD","LU1439102457.SGD","LU1316542783.SGD","LU0054237671.USD","LU3063872942.SGD","LU1688375341.USD","LU0441854154.USD","LU2237443549.SGD","LU0096374516.USD","LU1522347837.USD","LU0029875118.USD","LU1064131003.USD","LU1804176565.USD","LU0708995153.HKD","BK1191","LU1242518857.USD","LU1655091459.SGD","LU1439103000.SGD","LU1634259391.SGD","LU0784639295.USD","LU0228659784.USD","LU0048597586.USD","IE00BZ08YT58.USD","TCEHY","LU0972618739.USD","SG9999006597.SGD","IE00BQXX3F31.USD","LU1152091168.USD","LU0106252389.USD","LU0675040207.SGD","SG9999004220.SGD","00700","IE0008369823.USD","LU1734074674.USD","SG9999001903.USD","LU1226288253.USD","LU0588545730.USD","SGXZ81514606.USD","LU2362540622.SGD","IE00BZ08YR35.GBP","LU1769817179.HKD","LU0823426480.USD","LU0345769631.USD","LU0683595622.HKD","LU2251237306.USD","LU0577902611.USD","LU0261947096.USD","LU1497734951.SGD","LU2251237488.HKD","LU0588546209.SGD","LU0819123356.HKD","LU0648948544.HKD","SG9999013353.USD","LU1883866441.USD","LU1733274390.USD","LU0985320562.USD","BK1517","LU0293314216.USD","LU0231483743.USD","LU1102505762.USD","LU1023057109.AUD","LU1282648689.USD","LU2039709279.SGD","IE0034224299.USD","LU0572944931.SGD","LU0463099449.HKD","LU0211331839.USD","LU1917777945.USD","IE0032431581.USD","LU2051468812.USD","LU0738912210.USD","BK1516","LU2265009873.SGD","HTCD.SI","IE00BGHQDM52.EUR","LU0196878994.USD","HK0000352382.USD","LU1770034418.SGD","LU1196710351.USD","LU1808992512.USD","LU1242518931.SGD","BK1618","LU2008162690.USD","LU2663582299.SGD","LU0049112450.USD","LU1226287792.SGD","LU1044874839.SGD","LU0181495838.USD","LU2087589342.USD","LU0173614495.USD","LU2237443895.HKD","SG9999006514.SGD","LU1226288097.SGD","00101","LU0345776255.USD","IE00B031HY20.USD","LU0070217475.USD","LU0320764755.SGD","LU1880383366.USD","LU0561508036.HKD","LU0605514214.HKD","LU1993786604.SGD","BK1526","LU0235996351.USD","LU1769817096.USD","LU0329678337.USD","LU0786609619.USD","LU1048588211.SGD","BK1221","LU1226288170.HKD","LU0175139822.USD","LU0264606111.USD","00003","LU0608807946.USD","LU2097828557.USD","SG9999014914.USD","LU1008478684.HKD","LU2023250504.SGD","IE0009570106.USD","LU1044876610.USD","LU0261950983.USD","LU0192582467.USD","IE0008368411.USD","LU1960683339.HKD","IE00B5MMRT66.SGD","IE0031814852.USD","IE00B031HW06.USD","LU0501845795.SGD","LU2133065610.SGD","LU0543330566.HKD","LU1568876335.HKD","LU2293587155.HKD","SG9999015952.SGD","LU0384037296.USD","LU0048388663.USD","LU0823040885.USD","IE00B067MR52.USD","LU0214875030.USD","IE00BQXX3D17.EUR","LU0502904849.HKD","LU0370786039.SGD","LU0823426308.USD","LU0880133367.SGD","LU1196710195.USD","LU0862451837.USD","IE00B0JY6N72.USD","LU2257852520.SGD","IE00BGV7N243.SGD","LU0163747925.USD","SG9999014906.USD","LU0051755006.USD","LU0359201612.USD","LU0868486357.SGD","BK1555","LU0823413587.USD","LU0359202008.SGD","LU0828238088.HKD","LU0955623706.USD","LU2237443622.USD","LU0127658192.USD","LU0348788117.USD","SG9999001093.SGD","SGXZ51526630.SGD","LU0228367735.SGD","LU0819121731.USD","LU1868838027.USD","SG9999001069.SGD","LU0210526637.USD","LU0359201885.HKD","01177","LU0203345920.USD","BK1515","LU0572939691.SGD","LU1328277881.USD","IE00BVYPNQ40.USD","IE00B8HQ1Z84.USD","LU0509642566.USD","SG9999000459.SGD","LU0417516902.SGD","LU0307460666.USD","LU1497733631.SGD","LU0823397285.USD","LU0414403682.SGD","LU0589944569.HKD","LU0203347892.USD","BK1586","LU0229945570.USD","TCHmain","LU0140636845.USD","BK1095","LU0516422952.EUR","LU0577902298.EUR","LU0823397103.USD","SG9999001689.USD","LU0164865239.USD","LU0188438112.USD","LU0169518387.USD","LU0244354667.USD","LU1794554557.SGD","SG9999014674.SGD","LU2317271919.USD","03145","LU0080751232.USD","LU0314109678.HKD","LU0210533765.USD","SBHMY","LU1282649067.USD","LU0067412154.USD","LU1675838814.USD","LU0164880469.USD","IE0003851619.USD","LU1064130708.USD","LU2152927971.USD","LU1051768304.USD","LU0348827113.USD","LU0918141705.HKD","GB00BDT5M118.USD","LU0823038988.USD","LU1048484197.HKD","LU0572940350.SGD","LU0011963245.USD","LU1634259557.SGD","LU1497733557.USD","LU1868837722.USD","HLPPY","LU0541502299.USD","LU2399975544.HKD","LU0633140560.USD","LU0516422366.SGD","SG9999001846.SGD","LU2242644610.SGD","03143","LU0348805143.USD","LU1366334651.USD","LU0049853897.USD","LU1568876251.USD","LU0329678170.USD","LU0791590937.USD","LU0878005551.USD","LU1720050803.USD","LU0541501648.USD","LU0348814723.USD","LU0259732245.USD","LU0117844026.USD","LU2247934214.USD","LU1807302812.USD","BK1507","LU0455707207.USD","LU0700851271.USD","SG9999018865.SGD","LU0737861699.HKD","LU2778985437.USD","LU1051769294.HKD","LU1211504680.USD","LU0588545904.SGD","LU2125910849.SGD","LU0345769128.USD","LU0862451753.SGD","HK0000352291.HKD","LU1226287529.USD","SG9999015986.USD","LU0516423091.SGD","HOKCY","LU0540923850.HKD","LU0531970944.HKD","LU1196710864.SGD","LU1366334578.USD","LU0348783662.USD","LU2097828714.EUR","LU0456827905.SGD","LU2362541513.USD","BK1591","SG9999018857.SGD","LU1813983027.USD","LU0029874905.USD","LU0449515922.USD","IE00BF5LJ272.USD","LU1188198961.HKD","LU0634319403.HKD","LU0320764599.SGD","LU1130305938.SGD","SGXZ31699556.SGD","LU1235295612.USD","LU0737861772.HKD","SG9999000418.SGD","LU0328353924.USD","IE00BZ08YS42.EUR","LU1328615791.USD","SG9999000327.SGD","LU0348783233.USD","LU0642271901.SGD","02388","HK0000165453.HKD","LU0149721374.USD","LU1481107354.HKD","IE00B8L5B284.USD","BK1560","LU0611395673.USD","LU2045819591.USD","LU2237443465.HKD","LU1629966141.USD","LU0254981946.USD","BK1615","LU0231459107.USD","LU2498475776.HKD","IE00B0169L03.USD","LU0054450605.USD","LU0117841782.USD","LU0882747503.HKD","LU0594300179.USD","LU0588545490.SGD","BK1608","LU0128522157.USD","LU0345775950.USD","LU0797268264.HKD","LU2097828631.EUR","HK0000914686.HKD","LU2097828474.EUR","LU0348723411.USD","LU0417516738.SGD","LU0269904917.USD","LU0608807433.USD","LU0348825331.USD","LU1282649141.HKD","LU0918141887.USD","SG9999015945.SGD","LU1814569148.SGD","LU1226287875.USD","LU1303224171.USD","SG9999014898.SGD","LU0890818403.SGD","LU0878004406.USD","LU0831103253.SGD","LU0873338254.USD","LU1224709979.USD","SGXZ99366536.SGD","BK1609","LU1719994722.HKD","LU0456846285.SGD","LU0594300419.USD","IE00B29SXG58.USD","LU0128522744.USD","LU0048580855.USD","LU0898667661.SGD","LU0823413660.USD","SG9999002828.SGD","LU1152091754.HKD","BK1610","SG9999002463.SGD","LU0396098781.USD","LU0106259558.USD","IE0001KFT4U8.USD","LU1642822792.SGD","IE00BQXX3C00.GBP","LU0348735423.USD","SGXZ90724238.SGD","IE00B543WZ88.USD","LU2097828805.USD","LU2279701549.SGD","LU0431992006.USD","LU0043850808.USD","LU0210527791.USD","LU2177674079.SGD","LU0955669360.SGD","LU1251922891.USD","LU1048596156.SGD","LU1224444064.USD","LU0516422440.USD","LU0651946864.USD","IE00B97KM107.HKD","LU0499858438.USD","SG9999002562.SGD","LU0449509016.USD","IE00B031J352.USD","LU0143863198.USD","HK0000306685.HKD","LU0143863784.USD","LU0211977185.USD","LU0531971595.HKD","LU0823039010.USD","LU1961090484.USD","BK1531","IE0008368742.USD","LU0791591158.USD","BK1521","SG9999001226.SGD","LU0052750758.USD","BK1502","HK0000320223.HKD","LU1785774172.SGD","BK1229","SG9999003461.SGD","LU0149534421.HKD","LU0164872284.USD","SG9999001051.SGD","LU2462611646.USD","LU2237443978.SGD","LU1504937902.USD","IE00BPRC5H50.USD","LU0651947912.USD","LU0543330483.HKD","LU2476274720.SGD","LU0039217434.USD","LU1044875133.USD","LU1282651121.HKD","BK1577","LU1880383440.USD","LU0979878070.USD","LU0708995583.HKD","IE0032834883.USD","LU1770036033.HKD","LU2148510915.USD","LU1102505929.USD","BK1572","LU1733274473.HKD","IE00B0169N27.USD","HK0000306701.USD","LU2449936058.SGD","LU1718418525.SGD","LU1981816686.USD","BHKLY","LU0828237940.HKD","BK1231","LU0106959298.USD","BK1589","LU0072913022.USD","LU0650527681.SGD","BK1601","LU0315178854.USD","IE0003795394.USD","LU2125910500.SGD","LU0488056044.USD","LU0577902454.USD","LU0577902538.SGD","LU0107464264.USD","LU1515016050.SGD","LU0865486749.SGD","LU0327786744.USD","SG9999017495.SGD","LU0469268626.HKD","BK1258","LU0348816934.USD","LU0165289439.USD","LU0326950275.SGD","LU1956131251.USD","IE00B3M56506.USD","LU1282649810.SGD","LU0823041008.USD","LU1831875114.USD","LU2226246903.HKD","LU0672654166.SGD","LU0072462343.USD","LU0061477393.USD","LU0856984785.SGD","SG9999014880.SGD","LU1810669033.SGD","LU0348784397.USD","LU0456842615.SGD","LU0417516571.SGD","LU1508157978.USD","HK0000320264.USD","LU0084288322.USD","LU0607220059.USD","LU0251144936.SGD","LU0871576103.HKD","LU1868837565.USD","IE00BVYPNP33.GBP","LU0326948709.USD"],"gpt_icon":0},{"id":"2610921266","title":"港股指數早盤衝高回落 恒指半日升0.54 受壓居前  新東方(09901)跌4.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610921266","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610921266?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 12:29","pubTimestamp":1770697766,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股指数早盘冲高回落，截至午间收盘，恒指升0.54%，恒科指升0.84%，国企指升0.78%。据灯塔专业版，截至2月9日20时，2026春节档新片预售总票房已突破7000万元。三大航集体受压，中国国航跌4.89%，中国东航跌4.14%，中国南航跌2.95%。此外，Kling的典型视频生成时间约 86.4 秒，快于 Sora 2 Pro的449.6秒。该机构表示，预计快手在2025年四季度总营收及调整后净利润将分别实现增长，KlingAI收入可能继续超预期增长。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974861","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03690","00960","09901","LU0048580855.USD","LGFRY","LU1023057109.AUD","LU0502904849.HKD","MPNGY","02269","BK4526","LU0359201612.USD","LU1969619763.USD","LU0164865239.USD","LU0370786039.SGD","BK1556","BK4563","LU2242644610.SGD","00027","LU0327786744.USD","SG9999002950.SGD","BK4503","BK4588","LU2517655291.USD","BK4204","BK4506","LU0605514214.HKD","LU0039217434.USD","SG9999001093.SGD","IE0034224299.USD","LU0307460666.USD","LU0588546209.SGD","BK1519","SG9999006597.SGD","HHImain","LU0871576103.HKD","WXXWY","BK4531","513600","HSCEI","HSTECH","09992","BK4535","PMRTY","06862","01177","BK4509","HSI","MCHmain","LU0594300419.USD","LU2517655374.HKD","BK4614","BK4585","BK1588","SBHMY","SG9999001069.SGD","LU0531971595.HKD","LU0823426308.USD","LU0594300179.USD","LU0572944931.SGD","LU0455707207.USD","SG9999001051.SGD","EDU","BK4510","01801","BK1596","02833","LU0650527681.SGD","LU0359202008.SGD","01093","BK1228","LU0823426480.USD","LU2517655028.SGD","LU2328871848.SGD","BK4505"],"gpt_icon":0},{"id":"2606203862","title":"醫藥生物行業周報：併購與授權合作持續活躍，關注創新藥領域資源整合加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2606203862","media":"上海证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606203862?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 12:06","pubTimestamp":1769486783,"startTime":"0","endTime":"0","summary":"主要观点近期多起大额交易凸显创新药领域资源整合加速。通过此次收购，中国生物制药将获得siRNA赛道领先的自主技术平台、多元化产品管线及专业研发团队，丰富在大慢病领域的管线布局。目前，荣昌生物正在中国开展RC148单药及联合疗法治疗多种晚期恶性实体瘤患者的临床研究。投资建议我们认为，近期创新药领域并购与授权合作将持续活跃，中国创新药资产的全球认可度正在显著上升，资源整合加速，推动全球化布局与差异化发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127120632a6b14341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127120632a6b14341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007","02268","01875"],"gpt_icon":0},{"id":"2606016224","title":"中國生物製藥慢乙肝1類新藥Ⅱ期臨床達主要終點，為低病毒血症提供新方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2606016224","media":"正大制药订阅号","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606016224?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 07:01","pubTimestamp":1769468467,"startTime":"0","endTime":"0","summary":"近日，中国生物制药核心企业正大天晴宣布，其针对慢性乙型肝炎病毒感染的口服1类新药——核心蛋白变构调节剂TQA3605在Ⅱ期临床研究中达到主要研究终点。临床现有抗病毒药物如核苷（酸）类药物可以有效抑制HBV复制，但部分患者仍存在应答不佳及低病毒血症，危害不容忽视。此外，低病毒血症患者的疾病进展风险更高，肝细胞癌发生率是病毒完全抑制者的2-4倍甚至更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012707062897a37ab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012707062897a37ab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1589","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD","SBHMY","BK1521","IE00BZ08YR35.GBP","01177","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2595360726","title":"25年恒指累漲近28%：中國宏橋暴漲203.72%居成份股榜首，近10只個股翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2595360726","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595360726?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 14:31","pubTimestamp":1767162708,"startTime":"0","endTime":"0","summary":"港股2025年行情收官，恒生指数累涨27.77%，创下自2017年以来最佳年度表现。恒指成份股中，中国宏桥暴涨203.72%居榜首，紫金矿业涨162.29%，中芯国际涨124.69%，翰森制药涨113.33%，泡泡玛特涨111.46%，信达生物涨108.33%，周大福涨100.16%，中国生物制药涨98.71%，京东健康涨97.51%，中国人寿涨96.60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231143205a6e452f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231143205a6e452f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","CJEWY","LU0307460666.USD","02628","LU1023057109.AUD","02833","LU1719994722.HKD","601628","LU1770034418.SGD","01801","MCHmain","LU0359202008.SGD","LU0469268626.HKD","BK1500","ZIJMY","LU0702159699.USD","LU0264606111.USD","LU0359201885.HKD","01177","LU0359201612.USD","HHImain","HSI","LU1166156734.SGD","LU1251922891.USD","513600","LU1303224171.USD","LU0173614495.USD","LU0572939691.SGD","01929","LU0588546209.SGD","688981","LU0287142896.SGD","LU0572940350.SGD","BK1175","BK1594","PMRTY","BK1592","LU1224709979.USD","SG9999001093.SGD","MHImain","03692","SBHMY","06618","LU0737861699.HKD","01378","601899"],"gpt_icon":0},{"id":"2594235936","title":"中國生物製藥獲副總裁兼執行董事謝炘增持100萬股 每股作價約6.41港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594235936","media":"新浪网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594235936?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 08:18","pubTimestamp":1766621894,"startTime":"0","endTime":"0","summary":"热点栏目自选股数据中心行情中心资金流向模拟交易客户端香港联交所最新资料显示，12月24日，副总裁兼执行董事谢炘增持中国生物制药100万股，每股作价6.4068港元，总金额为640.68万港元。增持后最新持股数目约为3.61亿股，最新持股比例为1.92%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225102536a47593c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225102536a47593c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007"],"gpt_icon":0},{"id":"2594869802","title":"18款1類新藥首次獲批臨床！中國生物製藥2025年多領域創新破局，全球化研發體系再深化","url":"https://stock-news.laohu8.com/highlight/detail?id=2594869802","media":"正大制药订阅号","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594869802?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 07:02","pubTimestamp":1766617330,"startTime":"0","endTime":"0","summary":"临床前研究显示，TQB2101在多种ROR1阳性肿瘤模型中展现出抗肿瘤活性，且具有良好的安全性特征。2025年，中国生物制药共有3款PROTAC新药首次获得临床批准。非临床研究显示，TQB3201脱靶风险低、遗传毒性阴性、生殖毒性可逆，较目前在研同类产品活性更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225070854a474e3cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225070854a474e3cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","BK1589","BK1515","BK1191","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","SBHMY"],"gpt_icon":0},{"id":"2593804455","title":"熱搜第一！「進口抗癌假藥」1500元一盒，有效成分卻為0","url":"https://stock-news.laohu8.com/highlight/detail?id=2593804455","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593804455?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 21:27","pubTimestamp":1766410055,"startTime":"0","endTime":"0","summary":"经检测发现，该版本药品中安罗替尼的含量为0，即“境外版”安罗替尼本质上是完全没有有效成分的假药。该药物在国内流通后，因下游层层加价，一般患者购买的价格在1500元左右一盒，每盒的药量是正版的三倍。公安机关将患者家属提供的剩余药品送至鉴定机构检测，鉴定结论和上述药企的结论一致，即该安罗替尼“仿制药”中未检出安罗替尼成分。由此，连云港市市场监督管理局认定，涉案相关药品可以认定为假药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230225a46afb02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230225a46afb02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1521","IE00BZ08YT58.USD","01177","SBHMY","BK1515","BK1191","BK1589","HK0000165453.HKD"],"gpt_icon":0},{"id":"2590377896","title":"【券商聚焦】中州國際指恒指短期承壓，關注醫藥及能源板塊","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377896","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377896?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 11:30","pubTimestamp":1765337434,"startTime":"0","endTime":"0","summary":"金吾财讯|中州国际发布研报指，12月9日恒生指数收报25,434点，跌1.29%，成交2,102亿港元；国企指数跌1.62%至8,936点；恒生科技指数收跌1.90%报5,554点。美国9月CPI同比3.0%低于预期，美联储10月下调利率至3.75-4.00%区间。能源板块中，中国海洋石油第三季度营收1,049亿元人民币，当前市盈率7.71倍低于10年平均33.34倍，股息收益率6.38%。地缘政治及美联储政策仍将影响港股表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210115012a72ec76d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210115012a72ec76d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","HSCEI","HHImain","02833","MHImain","02269","BK1515","01177","600938","513600","HSI","00883","BK1161","WXXWY","SBHMY","BK1574","MCHmain"],"gpt_icon":1},{"id":"2589829615","title":"脱髮新藥III期成功；創新藥出海新模式誕生","url":"https://stock-news.laohu8.com/highlight/detail?id=2589829615","media":"药创新","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589829615?lang=zh_tw&edition=fundamental","pubTime":"2025-12-06 17:01","pubTimestamp":1765011660,"startTime":"0","endTime":"0","summary":"科伦博泰与Crescent达成“双向授权”交易，中国创新药出海再添新玩法；雄激素脱发新药III期临床成功，预计明年申报上市；中国药品价格登记系统上线，面向企业和全球开放查询；默克中国宣布重要任命；FDA再现人事动荡……若Crescent近期发生控制权变更或与第三方签订分许可协议，科伦博泰亦有资格向Crescent收取额外款项。阅读详情>>研发动态雄激素脱发新药III期成功12月4日，Cosmo Pharmaceuticals宣布，Clascoterone用于治疗男性雄激素性脱发的两项关键III期试验中取得积极结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206170552a437ab11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206170552a437ab11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","III","BK4134","BK4007"],"gpt_icon":0},{"id":"2579462065","title":"利好密集來襲！創新藥概念大爆發","url":"https://stock-news.laohu8.com/highlight/detail?id=2579462065","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579462065?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:54","pubTimestamp":1761904444,"startTime":"0","endTime":"0","summary":"据证券时报报道，今年国家医保谈判在延续医保目录常规调整机制的基础上，首次正式引入“商保创新药目录”机制。此外，年内国产创新药“出海”进程明显提速。根据医药魔方NextPharma数据库，截至10月21日，中国创新药今年对外许可共发生115起，金额总计达到1012.4亿美元，远超2024年全年的519亿美元。国信证券指出，中国创新药产业已经体现出长期向好的发展趋势，并在近年集中体现在BD交易的爆发式增长。配置上，看好创新药长期逻辑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02552","SBHMY","06990","01952","BK4007","03759","09995"],"gpt_icon":0},{"id":"2579245144","title":"2025年西藥行業市場發展現狀趨勢分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2579245144","media":"中研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579245144?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:39","pubTimestamp":1761903584,"startTime":"0","endTime":"0","summary":"2025年西药行业市场发展现状趋势分析在人口老龄化加速、医疗技术革新与政策红利的三重驱动下，中国西药行业正经历从“规模扩张”到“质量跃升”的关键转型。据中研产业研究院《2025-2030年中国西药行业竞争分析及发展前景预测报告》分析二、西药产业链及市场规模1. 上游：原料药国产化与CDMO崛起原料药是西药产业的基石。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","SBHMY","BK1583","01276","BK1574","LU0320764599.SGD","06160","09969","03692","BK1576","01093","01801","06978","09995","02359","LU0052750758.USD","LU2045819591.USD","02196","BK1141","BK1161","LU0708995583.HKD","LU2242644610.SGD","01177","LU2125910500.SGD"],"gpt_icon":0},{"id":"2579167282","title":"中國生物製藥又一款 1 類新藥首次啓動臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2579167282","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579167282?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 14:12","pubTimestamp":1761804767,"startTime":"0","endTime":"0","summary":"10 月 29 日，中国药物临床试验登记与信息公示平台显示，中国生物制药旗下泰德制药1 类新药注射用 TRD208 启动首个临床试验。截图来源：药物临床试验登记与信息公示平台TRD208 是一款非阿片类双模式长效镇痛1 类创新药，融合了神经传导阻滞和抗炎的双重机制，临床前数据显示其对于中度急性疼痛具有显著获益。9 月，该药在国内获批临床，默示许可适应症为成人术后镇痛，并于近日正式启动临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030141540a6d61d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030141540a6d61d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1191","01177","BK1515","BK1589","IE00BZ08YS42.EUR","SBHMY","BK1521"],"gpt_icon":0},{"id":"2575288909","title":"中國生物製藥(1177HK)：PDE3/4抑制劑II期臨床數據亮眼 市場潛力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2575288909","media":"招银国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575288909?lang=zh_tw&edition=fundamental","pubTime":"2025-10-13 00:00","pubTimestamp":1760284800,"startTime":"0","endTime":"0","summary":"中国生物制药在欧洲呼吸学会2025 年会上公布了其PDE3/4 抑制剂TQC3721 的II 期临床结果，临床结果显示TQC3721 可快速改善患者肺功能和症状。临床数据表明TQC3721 具备同类最佳潜力。PDE3/4 药物市场潜力巨大，竞争格局良好。默沙东在今年7 月宣布以100 亿美元收购Verona，体现PDE3/4 抑制剂巨大的市场潜力。作为全球进度第二且唯一处在III 期临床的PDE3/4 抑制剂，我们认为TQC3721 具备重磅海外授权潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101310413494c5896a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101310413494c5896a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007"],"gpt_icon":0},{"id":"2571800933","title":"大健康行業周報 |13億，「中國美敦力」完成交割；東星醫療：擬以支付現金方式購買武漢醫佳寶90%的股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2571800933","media":"保观","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571800933?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 12:04","pubTimestamp":1759118650,"startTime":"0","endTime":"0","summary":"保观 |聚焦保险创新国内篇行业动态13亿，“中国美敦力”完成交割近日，上海生物医药并购基金携手浦东创投集团旗下引领区基金，完成收购日本大冢集团所持微创医疗股份的交割，交易金额达13亿元人民币，上海生物医药并购基金成为微创医疗重要战略股东，持股约7.3%。此次交割完成后，被视为“中国美敦力”的微创医疗股价在港股市场表现活跃，市值突破200亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0008369823.USD","BK1606","LU1152091168.USD","06160","BK1515","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1226287792.SGD","BK1593","LU1226288253.USD","LU2543165471.USD","LU1008478684.HKD","01093","LU2039709279.SGD","BK1197","BK1570","LU0072913022.USD","IE0008368742.USD","LU0067412154.USD","LU1969619763.USD","00570","LU1226287875.USD","LU0315179316.USD","LU1719994722.HKD","00874","LU1960683339.HKD","IE00B543WZ88.USD","BK1500","LU0326950275.SGD","LU1251922891.USD","LU0588546209.SGD","01276","IE00B031HY20.USD","SBHMY","03320","BK1191","03692","03933","02196","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1023057109.AUD","LU1328277881.USD","LU1226287529.USD","01177","LU1152091754.HKD","LU2328871848.SGD","IE00BZ08YR35.GBP","LU0359201885.HKD","LU1226288170.HKD","LU1303224171.USD"],"gpt_icon":0},{"id":"2571782687","title":"華源證券-醫藥行業周報信立泰：全面佈局CKM管線，創新出海加速推進-250928","url":"https://stock-news.laohu8.com/highlight/detail?id=2571782687","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571782687?lang=zh_tw&edition=fundamental","pubTime":"2025-09-28 23:02","pubTimestamp":1759071720,"startTime":"0","endTime":"0","summary":"全面布局CKM管线，创新出海加速推进。我们认为信立泰创新研发已经迎来重大蜕变，公司全面布局心血管-肾脏-代谢慢病领域，在研管线涵盖高血压、血脂异常、心衰、代谢、肾科等多个领域，并布局单抗、多抗、ADC、多肽、环肽、基因编辑等新型技术平台，多款产品已经进入到临床阶段，不断强化公司在中国慢病领域综合性龙头地位。我们看好信立泰基于心血管为核心的CKM创新管线布局，带动公司成长为中国综合性慢病领域创新药龙头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092900142997af3c80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092900142997af3c80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0067412154.USD","BK1515","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1226288253.USD","BK1191","LU2039709279.SGD","LU0359201885.HKD","BK1574","LU1226288170.HKD","LU1226287529.USD","LU0315179316.USD","LU1813983027.USD","IE00BZ08YS42.EUR","LU1152091168.USD","LU1226287792.SGD","LU1993786604.SGD","SBHMY","IE00BZ08YT58.USD","LU0359201612.USD","LU0501845795.SGD","01177","LU1951186391.HKD","LU1023057109.AUD","03692","LU0072913022.USD","LU0140636845.USD","BK1589","IE0008369823.USD","IE00B543WZ88.USD","BK1521","LU0359202008.SGD","LU0326950275.SGD","SG9999004220.SGD","BK1161","IE00B5MMRT66.SGD","09926","01093","LU0880133367.SGD","01276","LU1960683339.HKD","LU2543165471.USD","BK1583","IE0008368742.USD","LU1152091754.HKD","LU0314109678.HKD","LU1008478684.HKD","LU1226287875.USD","06978","LU1807302812.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}